Under-ice phytoplankton blooms inhibited by spring convective mixing in refreezing leads

Author Posting. © American Geophysical Union, 2018. This article is posted here by permission of American Geophysical Union for personal use, not for redistribution. The definitive version was published in Journal of Geophysical Research: Oceans 123 (2018): 90–109, doi:10.1002/2016JC012575.Spring phytoplankton growth in polar marine ecosystems is limited by light availability beneath ice-covered waters, particularly early in the season prior to snowmelt and melt pond formation. Leads of open water increase light transmission to the ice-covered ocean and are sites of air-sea exchange. We explore the role of leads in controlling phytoplankton bloom dynamics within the sea ice zone of the Arctic Ocean. Data are presented from spring measurements in the Chukchi Sea during the Study of Under-ice Blooms In the Chukchi Ecosystem (SUBICE) program in May and June 2014. We observed that fully consolidated sea ice supported modest under-ice blooms, while waters beneath sea ice with leads had significantly lower phytoplankton biomass, despite high nutrient availability. Through an analysis of hydrographic and biological properties, we attribute this counterintuitive finding to springtime convective mixing in refreezing leads of open water. Our results demonstrate that waters beneath loosely consolidated sea ice (84–95% ice concentration) had weak stratification and were frequently mixed below the critical depth (the depth at which depth-integrated production balances depth-integrated respiration). These findings are supported by theoretical model calculations of under-ice light, primary production, and critical depth at varied lead fractions. The model demonstrates that under-ice blooms can form even beneath snow-covered sea ice in the absence of mixing but not in more deeply mixed waters beneath sea ice with refreezing leads. Future estimates of primary production should account for these phytoplankton dynamics in ice-covered waters.National Science Foundation (NSF) Grant Numbers: PLR-1304563 , PLR-1303617; KEL; NSF Graduate Research Fellowship Program Grant Number: DGE-06459622018-07-0

Effects of Iron and Light Availability on Phytoplankton Photosynthetic Properties in the Ross Sea

Waters of the Southern Ocean are characterized by high macronutrient concentrations but limited availability of trace metals and light, often making it difficult for phytoplankton to achieve maximum growth rates. One strategy employed by Southern Ocean phytoplankton in culture to cope with low light and low dissolved iron (DFe) is to enhance light absorption by increasing their antenna size rather than the number of reaction centers, thereby reducing their Fe demand. Here we provide physiological evidence that natural populations of Southern Ocean phytoplankton employ a similar photoacclimation strategy to cope with low ambient DFe concentrations. During a research cruise to the Ross Sea in 2013-2014, we conducted 4 bioassay experiments in which we manipulated light and DFe concentrations and measured changes in phytoplankton biomass, growth rate, photosynthetic parameters, fluorescence parameters, and pigment composition. Phytoplankton responded strongly to DFe additions, exhibiting significantly higher biomass, growth rates, and photosynthetic competency. At low light, the maximum photosynthetic rate (P*max) was significantly reduced and the photosynthetic efficiency (α*) was unchanged compared to the high light treatment, regardless of phytoplankton species composition or DFe concentration. Our data suggest that Southern Ocean phytoplankton have evolved an Fe-saving strategy whereby they photoacclimate to low light by increasing their photosynthetic unit size, rather than photosynthetic unit number, even when DFe is available. It appears this Fe-saving strategy is characteristic of both Phaeocystis antarctica and diatoms, suggesting that it is a common adaptation among phytoplankton taxa that grow under Fe limitation in the Southern Ocean

Early Spring Phytoplankton Dynamics in the Western Antarctic Peninsula

The Palmer Long-Term Ecological Research program has sampled waters of the western Antarctic Peninsula (wAP) annually each summer since 1990. However, information about the wAP prior to the peak of the phytoplankton bloom in January is sparse. Here we present results from a spring process cruise that sampled the wAP in the early stages of phytoplankton bloom development in 2014. Sea ice concentrations were high on the shelf relative to nonshelf waters, especially toward the south. Macronutrients were high and nonlimiting to phytoplankton growth in both shelf and nonshelf waters, while dissolved iron concentrations were high only on the shelf. Phytoplankton were in good physiological condition throughout the wAP, although biomass on the shelf was uniformly low, presumably because of heavy sea ice cover. In contrast, an early stage phytoplankton bloom was observed beneath variable sea ice cover just seaward of the shelf break. Chlorophyll a concentrations in the bloom reached 2 mg m^(−3) within a 100–150 km band between the SBACC and SACCF. The location of the bloom appeared to be controlled by a balance between enhanced vertical mixing at the position of the two fronts and increased stratification due to melting sea ice between them. Unlike summer, when diatoms overwhelmingly dominate the phytoplankton population of the wAP, the haptophyte Phaeocystis antarctica dominated in spring, although diatoms were common. These results suggest that factors controlling phytoplankton abundance and composition change seasonally and may differentially affect phytoplankton populations as environmental conditions within the wAP region continue to change

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. METHODS: In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. FINDINGS: Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1·4%, 95% CI -7·0 to 4·3; hazard ratio 0·96, 0·68-1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3-4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). INTERPRETATION: Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. FUNDING: UK National Institute for Health Research Health Technology Assessment

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Distribution of Phaeocystis antarctica-dominatedsea ice algal communities and their potential to seed phytoplankton across the western Antarctic Peninsula in spring

The western Antarctic Peninsula has experienced extreme changes in the timing of sea ice melt and freeze up, shortening the duration of the seasonal sea ice cycle. While previous research demonstrated connections between multiple pelagic trophic levels and the physics of the sea ice, few studies have assessed the sea ice ecosystem or its linkage to the ocean ecosystem in this region. Through a field survey and shipboard experiments, our study focused on characterizing the spring ice algal bloom and elucidating its role in seeding phytoplankton communities post-ice melt in high and low light conditions. Field data revealed that algal communities in slush layers, often formed from the flooding of seawater (infiltration layers), dominated biomass distributions in the sea ice throughout the region, and showed distinct photophysiological characteristics from interior or bottom ice communities. Sea ice algal biomass reached 120 mg chl a m−2 and was often dominated by Phaeocystis antarctica. Shipboard growth experiments showed that prior light history (ice or water column), rather than community composition (phytoplankton and ice algae were composed of similar taxa), primarily drove physiological responses to high and low light. P. antarctica generally dominated the community in growth experiments at the end of the 6 d incubation period. Settling column experiments suggested that P. antarctica’s higher sinking rates relative to other taxa may explain its minor contributions to the summer phytoplankton community in single-cell form and its absence in colonial form, observed in the long-term ecological record of this region